Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01586026 · ClinicalTrials.gov registry record
Study to Extend the Maximum Maintenance Flushing Interval for Ports With Distally Valved Catheters
A clinical trial, sponsored by C. R. Bard.
- Terminated
- Registry status
- 171
- Enrollment target
NCT01586026: Clinical Trial study, sponsored by C. R. Bard.
NCT01586026 is a clinical trial that was terminated before completion, run by C. R. Bard. The registered enrollment target is 171 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01586026 was terminated before completion, sponsored by C. R. Bard.
- TERMINATED
- Registry status
- 171 participants
- Enrollment target
Study Summary
This study is to compare the rate of adverse events in subjects with maintenance flushes greater than 28 days.
Primary Outcome
Subjects' maintenance flush intervals were collected by calculating the number of days since a previous flush. A total of 1,035 maintenance flush intervals were recorded at all sites. The numbers of flushing intervals available for analysis are 1,035 representing 49,696 patient days were recorded in 171 subjects.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 171 participants |
| Start Date | 2012-04 |
| Est. Completion | 2012-11 |
Why NCT01586026 stopped before completion
NCT01586026 is an observational study that tracks outcomes without assigning an intervention. The registered 171 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01586026 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01586026 about?
NCT01586026 is a clinical study titled "Study to Extend the Maximum Maintenance Flushing Interval for Ports With Distally Valved Catheters". This study is to compare the rate of adverse events in subjects with maintenance flushes greater than 28 days.
What is the current status of trial NCT01586026?
This trial is currently terminated. The enrollment target is 171 participants. The study started on 2012-04. Estimated completion is 2012-11.
Who is sponsoring clinical trial NCT01586026?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02641145 · 171 participants · NA
Molecular Imaging of Primary Amyloid Cardiomyopathy
- NCT05541029 · 171 participants · NA
Music Listening: A Mechanistic Trial
- NCT05561127 · 171 participants · Phase 3
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel
- NCT05592938 · 171 participants · NA
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia